Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients

被引：0
|
作者：
Takaya Uno
Kyoichi Wada
Sachi Matsuda
Yuka Terada
Akira Oita
Atsushi Kawase
Mitsutaka Takada
机构：
[1] National Cerebral and Cardiovascular Center,Department of Pharmacy
[2] Kindai University,Division of Clinical Drug Informatics, Faculty of Pharmacy
[3] Kindai University,Department of Pharmacy, Faculty of Pharmacy
[4] Kindai University Graduate School of Pharmacy,Division of Cardiovascular Drugs, Therapy
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2018年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：665 / 673
页数：8
相关论文
共 50 条
  • [21] CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients
    Xue, Feng
    Han, Longzhi
    Chen, Yikuan
    Xi, Zhifeng
    Li, Qigen
    Xu, Ning
    Xia, Yun
    Streicher, Katie
    Zhang, Jianjun
    Xia, Qiang
    PEDIATRIC TRANSPLANTATION, 2014, 18 (02) : 166 - 176
  • [22] Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms
    Zheng, HX
    Webber, S
    Zeevi, A
    Schuetz, E
    Zhang, J
    Bowman, P
    Boyle, G
    Law, Y
    Miller, S
    Lamba, J
    Burckart, GJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (04) : 477 - 483
  • [23] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
  • [24] CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
    Li, Yi
    Yan, Lin
    Shi, Yunying
    Bai, Yangjuan
    Tang, Jiangtao
    Wang, Lanlan
    SPRINGERPLUS, 2015, 4
  • [25] IMPACT OF CYP3A5, CYP3A4, AND ABCB1 GENOTYPES ON TACROLIMUS DOSING AND MONITORING IN LIVER TRANSPLANT PATIENTS
    Ladd, Alexandra
    Pahim, Isabella Angeli
    Warren, Curtis
    Duarte, Sergio
    Zarrinpar, Ali
    HEPATOLOGY, 2022, 76 : S1284 - S1285
  • [26] Influence of the Cyp3a5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients
    Ferraresso, Mariano
    Tirelli, Amedea
    Ghio, Luciana
    Grillo, Paolo
    Martina, Valentina
    Torresani, Erminio
    Edefonti, Alberto
    PEDIATRIC TRANSPLANTATION, 2007, 11 (03) : 296 - 300
  • [27] Effect of CYP3A5 and MDR1 gene polymorphism on pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Kato, T
    Habuchi, T
    JOURNAL OF UROLOGY, 2004, 171 (04): : 490 - 491
  • [28] Influence of CYP3A4*22 and CYP3A5*3 genetic polymorphisms on tacrolimus pharmacokinetics in adult renal transplant patients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S709 - S709
  • [29] CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients
    Renders, L.
    Frisman, M.
    Ufer, M.
    Mosyagin, I.
    Haenisch, S.
    Ott, U.
    Caliebe, A.
    Dechant, M.
    Braun, F.
    Kunzendorf, U.
    Cascorbi, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 228 - 234
  • [30] Effect of CYP3A5*3 on carbamazepine pharmacokinetics in Japanese patients with epilepsy
    Seo, T
    Nakada, N
    Ueda, N
    Hagiwara, T
    Hashimoto, N
    Nakagawa, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (05) : 509 - 510
12345